Page last updated: 2024-08-07 17:28:01
Leukotriene B4 receptor 2
A leukotriene B4 receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9NPC1]
Synonyms
LTB4-R 2;
LTB4-R2;
LTB4 receptor JULF2;
Leukotriene B4 receptor BLT2;
Seven transmembrane receptor BLTR2
Research
Bioassay Publications (9)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Compounds (20)
Drugs with Potency Measurements
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
sc 41930 | Homo sapiens (human) | IC50 | 2.0450 | 2 | 2 |
sc 41930 | Homo sapiens (human) | Ki | 0.0120 | 1 | 1 |
ly 255283 | Homo sapiens (human) | IC50 | 1.5250 | 2 | 2 |
ly 255283 | Homo sapiens (human) | Ki | 0.0850 | 1 | 1 |
rg 14893 | Homo sapiens (human) | IC50 | 0.0047 | 1 | 1 |
ly 293111 | Homo sapiens (human) | IC50 | 0.0033 | 1 | 1 |
ly 293111 | Homo sapiens (human) | Ki | 0.0170 | 1 | 1 |
cocaine | Homo sapiens (human) | Ki | 0.5240 | 1 | 1 |
leukotriene b4 | Homo sapiens (human) | Ki | 0.0019 | 1 | 1 |
cp 195543 | Homo sapiens (human) | IC50 | 0.0525 | 3 | 7 |
cp 105696 | Homo sapiens (human) | IC50 | 25.7128 | 3 | 3 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
candesartan | Homo sapiens (human) | EC50 | 15.0000 | 1 | 1 |
avapro | Homo sapiens (human) | EC50 | 0.4100 | 1 | 1 |
bw-755c | Homo sapiens (human) | EC50 | 6.8000 | 1 | 1 |
tepoxalin | Homo sapiens (human) | EC50 | 0.0700 | 1 | 1 |
zileuton | Homo sapiens (human) | EC50 | 0.4700 | 1 | 1 |
valsartan | Homo sapiens (human) | EC50 | 16.0000 | 1 | 1 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
nifedipine | Homo sapiens (human) | ID50 | 0.0100 | 1 | 1 |
Second-generation leukotriene B4 receptor antagonists related to SC-41930: heterocyclic replacement of the methyl ketone pharmacophore.Journal of medicinal chemistry, , Mar-17, Volume: 38, Issue:6, 1995
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.Journal of medicinal chemistry, , Oct-27, Volume: 38, Issue:22, 1995
Elucidation of Mechanism for Ligand Efficacy at Leukotriene BACS medicinal chemistry letters, , Aug-13, Volume: 11, Issue:8, 2020
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.Journal of medicinal chemistry, , Oct-27, Volume: 38, Issue:22, 1995
Enables
This protein enables 3 target(s):
Target | Category | Definition |
leukotriene receptor activity | molecular function | Combining with a leukotriene to initiate a change in cell activity. Leukotrienes are pharmacologically active substances with a set of three conjugated double bonds; some contain a peptide group based on cysteine. [GOC:ai, ISBN:0198506732] |
leukotriene B4 receptor activity | molecular function | Combining with leukotriene B4, LTB4, to initiate a change in cell activity. Leukotriene B4 is also known as (6Z, 8E, 10E, 14Z)-(5S, 12R)-5,12-dihydroxyicosa-6,8,10,14-tetraen-1-oate. [GOC:ai, ISBN:0198506732] |
G protein-coupled peptide receptor activity | molecular function | Combining with a peptide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. [GOC:dph, GOC:tb] |
Located In
This protein is located in 3 target(s):
Target | Category | Definition |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Involved In
This protein is involved in 5 target(s):
Target | Category | Definition |
chemotaxis | biological process | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). [ISBN:0198506732] |
negative regulation of adenylate cyclase activity | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of adenylate cyclase activity. [GOC:go_curators] |
keratinocyte migration | biological process | The directed movement of a keratinocyte, epidermal cells which synthesize keratin, from one site to another. [ISBN:0721662544] |
leukotriene signaling pathway | biological process | A G protein-coupled receptor signaling pathway initiated by leukotriene binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. [GOC:dph, PMID:21771892] |
neuropeptide signaling pathway | biological process | A G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. [GOC:mah, ISBN:0815316194] |